Indian Immunologicals Limited – Product Pipeline Review

Global Markets Direct’s, ‘Indian Immunologicals Limited – Product Pipeline Review – 2016’, provides an overview of the Indian Immunologicals Limited’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Indian Immunologicals Limited, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Indian Immunologicals Limited

The report provides overview of Indian Immunologicals Limited including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Indian Immunologicals Limited’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Indian Immunologicals Limited’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Indian Immunologicals Limited’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Indian Immunologicals Limited

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Indian Immunologicals Limited’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Indian Immunologicals Limited Snapshot 5

Indian Immunologicals Limited Overview 5

Key Information 5

Key Facts 5

Indian Immunologicals Limited - Research and Development Overview 6

Key Therapeutic Areas 6

Indian Immunologicals Limited - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Pipeline Products - Combination Treatment Modalities 10

Indian Immunologicals Limited - Pipeline Products Glance 11

Indian Immunologicals Limited - Clinical Stage Pipeline Products 11

Phase I Products/Combination Treatment Modalities 11

Indian Immunologicals Limited - Early Stage Pipeline Products 12

Preclinical Products/Combination Treatment Modalities 12

Indian Immunologicals Limited - Unknown Stage Pipeline Products 13

Unknown Products/Combination Treatment Modalities 13

Indian Immunologicals Limited - Drug Profiles 14

(diphtheria + Haemophilus influenza [serotype B] + hepatitis B + pertussis (wholl cell) + tetanus) (pentavalent) vaccine 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

chikungunya vaccine 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

human papillomavirus [serotypes 16, 18] vaccine 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

Japanese encephalitis vaccine 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Alphavirus vaccine 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

flavivirus vaccine 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

picornavirus vaccine 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Vaccine for Undisclosed Indication 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Indian Immunologicals Limited - Pipeline Analysis 22

Indian Immunologicals Limited - Pipeline Products by Target 22

Indian Immunologicals Limited - Pipeline Products by Route of Administration 23

Indian Immunologicals Limited - Pipeline Products by Molecule Type 24

Indian Immunologicals Limited - Recent Pipeline Updates 25

Indian Immunologicals Limited - Dormant Projects 26

Indian Immunologicals Limited - Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Appendix 28

Methodology 28

Coverage 28

Secondary Research 28

Primary Research 28

Expert Panel Validation 28

Contact Us 28

Disclaimer 29

List of Tables

List of Tables

Indian Immunologicals Limited, Key Information 5

Indian Immunologicals Limited, Key Facts 5

Indian Immunologicals Limited – Pipeline by Indication, 2016 7

Indian Immunologicals Limited – Pipeline by Stage of Development, 2016 8

Indian Immunologicals Limited – Monotherapy Products in Pipeline, 2016 9

Indian Immunologicals Limited – Combination Treatment Modalities in Pipeline, 2016 10

Indian Immunologicals Limited – Phase I, 2016 11

Indian Immunologicals Limited – Preclinical, 2016 12

Indian Immunologicals Limited – Unknown, 2016 13

Indian Immunologicals Limited – Pipeline by Target, 2016 22

Indian Immunologicals Limited – Pipeline by Route of Administration, 2016 23

Indian Immunologicals Limited – Pipeline by Molecule Type, 2016 24

Indian Immunologicals Limited – Recent Pipeline Updates, 2016 25

Indian Immunologicals Limited – Dormant Developmental Projects,2016 26

Indian Immunologicals Limited, Other Locations 27

List of Figures

List of Figures

Indian Immunologicals Limited – Pipeline by Top 10 Indication, 2016 7

Indian Immunologicals Limited – Pipeline by Stage of Development, 2016 8

Indian Immunologicals Limited – Monotherapy Products in Pipeline, 2016 9

Indian Immunologicals Limited – Pipeline by Route of Administration, 2016 23

Indian Immunologicals Limited – Pipeline by Molecule Type, 2016 24

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports